학술논문
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
Document Type
Article
Author
Source
In Molecular Immunology January 2024 165:29-41
Subject
Language
ISSN
0161-5890